Douglas S. Darling
Brigham and Women's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Douglas S. Darling.
Molecular and Cellular Biology | 1989
Mitchell A. Lazar; Richard A. Hodin; Douglas S. Darling; William W. Chin
A cDNA encoding a novel member of the thyroid/steroid hormone receptor superfamily, called Rev-ErbA alpha, has been isolated from a rat GH3 cell library. Rev-ErbA alpha is an approximately 56-kilodalton protein most similar in structure to the thyroid hormone receptor (c-erbA) and the retinoic acid receptor, but it does not bind either thyroid hormone or retinoic acid. The mRNA encoding Rev-ErbA alpha is present in many tissues and is particularly abundant in skeletal muscle and brown fat. A genomic DNA fragment containing the entire Rev-ErbA alpha cDNA sequence was isolated and characterized. Remarkably, this DNA fragment also contained a portion of the c-erbA alpha gene. r-erbA alpha-1 and r-erbA alpha-2 are alternative splice products of the c-erbA alpha gene and are members of the receptor superfamily. The genes encoding Rev-ErbA alpha and r-erbA alpha-2 overlap, with their coding strands oriented opposite one another. A 269-base-pair segment of the bidirectionally transcribed region is exonic in both the Rev-ErbA alpha and r-erbA alpha-2 genes, resulting in complementary mRNAs. Thus, through alternative splicing and opposite-strand transcription, a single genomic locus codes for three different members of the thyroid/steroid hormone receptor superfamily. Potential implications of this unusual genomic arrangement are discussed.
Recent Progress in Hormone Research | 1993
William W. Chin; Frances E. Carr; Joan Burnside; Douglas S. Darling
Thyroid hormones suppress the synthesis and release of thyrotropin from thyrotropes in the anterior pituitary gland, a feature that is critical in the classic negative-feedback loop of the pituitary-thyroid endocrine axis. The major effect of thyroid hormones in this system is exerted at the transcriptional level. The molecular mechanisms by which there is negative regulation of TSH subunit gene expression by thyroid hormone have been elucidated. The TSH subunit genes have isolated and characterized. Structure-function analyses using fusion genes and DNA transfection approaches have defined the putative negative TREs among the promoters of the rat, mouse, and human alpha and TSH beta genes. These sequences are either largely overlapping direct TRE half-sites, TRE half-sites as direct repeats gapped by two nucleotides, or single TRE half-sites. These arrangements are distinct from those seen in positive TREs. Recent knowledge regarding the molecular mechanisms of thyroid action in general forces consideration of multiple TR isoforms, TR heterodimer partners (TRAPs), and thyroid hormones in the ultimate mechanisms of negative action. Several models have been proposed, but none has yet been proved. In addition, the role of thyroid hormone in the regulation of gene expression at the posttranscriptional level is beginning to be addressed. Future work should continue to illuminate these important facets of gene regulation.
Science | 1989
Richard A. Hodin; Mitchell A. Lazar; Bi Wintman; Douglas S. Darling; Rj Koenig; Pr Larsen; David D. Moore; William W. Chin
Molecular Endocrinology | 1988
Mitchell A. Lazar; Richard A. Hodin; Douglas S. Darling; William W. Chin
Journal of Biological Chemistry | 1992
Paul M. Yen; Douglas S. Darling; R L Carter; M Forgione; P K Umeda; William W. Chin
Journal of Biological Chemistry | 1990
Joan Burnside; Douglas S. Darling; William W. Chin
Molecular Endocrinology | 1991
Douglas S. Darling; Jean S. Beebe; Joan Burnside; Elizabeth R. Winslow; William W. Chin
Journal of Biological Chemistry | 1989
Joan Burnside; Douglas S. Darling; Frances E. Carr; William W. Chin
Molecular Endocrinology | 1991
Amy L. O'Donnell; Evan D. Rosen; Douglas S. Darling; Ronald J. Koenig
Endocrinology | 1993
Akira Sugawara; Paul M. Yen; Douglas S. Darling; William W. Chin